Development
Lexicon Pharmaceuticals, Inc.
LXRX
$1.05
-$0.07-6.25%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 218.43M | 256.74M | 105.94M | 138.36M | 136.20M |
| Total Receivables | 318.00K | 685.00K | 261.00K | 28.00K | 39.00K |
| Inventory | 336.00K | 172.00K | -- | -- | -- |
| Prepaid Expenses | 4.29M | 6.12M | 3.35M | 2.48M | 2.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 223.37M | 263.72M | 109.55M | 140.87M | 139.06M |
|
|
|||||
| Total Current Assets | 223.37M | 263.72M | 109.55M | 140.87M | 139.06M |
| Net Property, Plant & Equipment | 7.82M | 8.46M | 8.63M | 8.89M | 8.08M |
| Long-term Investments | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Goodwill | 44.54M | 44.54M | 44.54M | 44.54M | 44.54M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 743.00K | -- | -- | -- | -- |
| Total Assets | 276.48M | 316.72M | 162.72M | 194.30M | 191.69M |
|
|
|||||
| Total Accounts Payable | 12.04M | 10.50M | 10.31M | 10.40M | 9.43M |
| Total Accrued Expenses | 18.93M | 14.32M | 8.77M | 11.49M | 7.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.29M | 1.29M | 1.29M | 1.29M | 1.41M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 32.26M | 26.11M | 20.37M | 23.17M | 18.45M |
|
|
|||||
| Total Current Liabilities | 32.26M | 26.11M | 20.37M | 23.17M | 18.45M |
| Long-Term Debt | 99.27M | 98.77M | 48.85M | 48.58M | 23.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.44M | 5.48M | 5.45M | 5.42M | 5.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 136.97M | 130.36M | 74.67M | 77.18M | 47.67M |
|
|
|||||
| Common Stock & APIC | 1.86B | 1.86B | 1.71B | 1.71B | 1.71B |
| Retained Earnings | -1.72B | -1.67B | -1.62B | -1.59B | -1.56B |
| Treasury Stock & Other | -3.00M | -2.99M | -3.05M | -2.49M | -2.55M |
| Total Common Equity | 139.51M | 186.36M | 88.05M | 117.12M | 144.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 139.51M | 186.36M | 88.05M | 117.12M | 144.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 139.51M | 186.36M | 88.05M | 117.12M | 144.02M |
|
|
|||||